Retatrutide 20mg (R&D Only)

€135.00

Technical Specifications

Specification	Detail
Product Name	Retatrutide (LY3437943) – R&D Only
CAS Number	2381089-83-2
Molecular Formula	C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight	4731.33 Da
Purity	≥99% (HPLC verified)
Appearance	White to off-white lyophilized solid
Solubility	H₂O: 20 mg/mL; DMSO: 50 mg/mL
Target Receptors	GLP-1R, GIPR, GCGR
Mechanism	Triple hormone receptor agonist
Storage (Powder)	-20°C to -80°C; protect from light/moisture
Storage (Reconstituted)	2-8°C for several weeks; aliquot for freezing
Stability (Powder)	2 years at -80°C; 1 year at -20°C
Stability (Solution)	6 months at -80°C; 1 month at -20°C
Shipping	Ambient with protective packaging
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis, Safety Data Sheet

Category: Buy Peptide Online EU Tags: 0.22 micron filter, 0.45 micron filter, 12pm delivery, 13C NMR, 1H NMR, 2 day delivery, 2 year bioassay, 24/7 monitoring, 2D NMR, 3D cell culture, 3D secure, 3PL warehousing, 3R principles, 3T3-L1 differentiation, 5 star peptide service, 505(b)(2) pathway, 9am delivery, abandoned cart, Absolute quantification, Academia.edu page, academic network, academic reputation, accelerated approval, accelerated stability, access request, accuracy, acetate content, acetylation, acid cabinet, active packaging, ADA scientific sessions, adequacy decision, adipocyte culture, adipogenesis assay, adipose tissue research, ADR compliance, advanced biotech research, advanced peptide synthesis, adverse event reporting, AEMPS Spain, affiliate program, AIFA Italy, alarm notification, AliPay, aliquot storage peptides, alkali cabinet, alternative methods, Ames test, amino acid analysis, amino acid sequencing, analogue laws, analytical chemistry conference, analytical HPLC data, analytical instruments show, analytical reagent, analytical run, analytical standard only, anaphylaxis, ANDA submission, animal study protocol, animal welfare, annealing step, ANSM France, anti counterfeit, anti drug antibody, Apple pay, applied research, AQUA peptide, aseptic handling, aseptic processing, ASR analyte specific reagent, assay test, assay validation, association rate, ATR certificate, ATR-FTIR, audit process, authenticity verification, autoradiography, AVS check, B2B transaction, B2C transaction, background correction, bacterial endotoxin, Balkan region delivery, Baltic states delivery, Bancontact, bank transfer EU, barcode scanning, basic science discovery, batch consistency, batch management, BCA assay peptide, BCRP, Bella Center Copenhagen, benefit risk assessment, Berlin ://about blank, Berlin Admiralspalast, Berlin Arena, Berlin Arena Club, Berlin Astra Kulturhaus, Berlin Berghain, Berlin Chalet, Berlin Club der Visionaere, Berlin Columbiahalle, Berlin Deutsche Oper, Berlin Else, Berlin Friedrichspalast, Berlin Golden Gate, Berlin Gretchen, Berlin Holzmarkt, Berlin Hoppetosse, Berlin Huxleys, Berlin IPSE, Berlin Kater Blau, Berlin KitKatClub, Berlin Komische Oper, Berlin Konzerthaus, Berlin Kulturbrauerei, Berlin Lido, Berlin Max-Schmeling-Halle, Berlin Mensch Meier, Berlin Mercedes-Benz Arena, Berlin OHM, Berlin Olympiastadion, Berlin Palace, Berlin Philharmonie, Berlin Radialsystem, Berlin Renate, Berlin RSO Berlin, Berlin Salon zur wilden Renate, Berlin Silent Green, Berlin Sisyphos, Berlin Staatsoper, Berlin Tempodrom, Berlin Theater des Westens, Berlin Tresor, Berlin Uber Arena, Berlin Velodrom, Berlin Verti Music Hall, Berlin Watergate, Berlin Weekend Club, Berlin Wilde Renate, best peptide vendor Europe, best place to buy peptides EU, best practice guideline, beta cell line, beta oxidation study, better stability, BfArM Germany, binding affinity, binding corporate rules, bioavailability, biobanking, bioburden test, biochemical research tool, biocompatibility, biologics development, biomarker analysis, biometric authentication, bioRxiv, biosafety cabinet certification, biosafety level 2, biosimilar comparability, biosimilar development, biotech convention, Biotech startup, biotechnology reagents, biotherapeutic characterization, Bitcoin, BLA submission, blank subtraction, blockchain payment, blockchain supply chain, Boc chemistry, Bochum RuhrCongress, body composition analysis, Bordeaux Lac, borosilicate vial, BP monograph, BPC-157 Europe, BPCRS, brand name drug, breakthrough therapy, Bremen Messe, Brussels Expo, buffer exchange, bulk peptide order Europe, business continuity plan, butyl stopper, buy GIP peptides, buy GLP-1 peptides, buy peptides EU, buy research compounds EU, buy Retatrutide online EU, c-peptide ELISA, cake appearance, Calcium flux, calibration curve peptide, calibration line, call off stock, cAMP accumulation, candidate selection, carbon footprint, carbon-14 labeled, Carcinogenicity, Cardiotoxicity, cardiovascular metabolic research, carnets, carryover, CBG-MEB Netherlands, CDMO, CE IVD mark, CE mark, cell free expression, cell signaling pathways, Central Europe delivery, centralized procedure, centrifugal filtration, centrifuge safety, certificate of origin, certified reference material, cGMP manufacturing, checkout optimization, chemical fume hood, chemical registration, chemical storage cabinet, chloride content, cholesterol assay, chromatogram analysis, chromosomal aberration, circular dichroism, citation index, class 1 solvent, class 2 solvent, class 3 solvent, cleanroom classification, clearance rate, clinical candidate, clinical study report, Clinical Trial Application (CTA), clinical trial material, clinical trial phases, cloud storage, CMO, cold chain logistics, cold chain validation, collaborative study, commercial invoice, commercial launch, commercial research peptides, commercial scale, commission pack, commodity code, comparator peptide, compendial method, composition of matter, comprar retatrutide España, concentration step, concentration verification, condenser temperature, conditional marketing authorization, conference sponsorship, confirmatory research, consent management, consent withdrawal, consignment stock, container closure system, Contamination control, contract manufacturing organization, controlled substances exemption, Convention Centre Dublin, conversion rate, cookie policy, copy exact peptide, corporate account, corporate social responsibility, COSHH assessment, Cost effectiveness analysis, COSY, Cottbus Messe, coupon code, courier service, covalent binding, CPHI worldwide, CREB phosphorylation, credit card payment, crimp seal, CRM system, CRO services peptides, cross border shipping, Cryptocurrency, CT imaging, custom peptide order, custom peptide synthesis, custom synthesis service, customer satisfaction guarantee, customer support chat, customs clearance EU, customs delay, CVV check, cyber security, cycle development, CYP450 inhibition, cytokine release, cytotoxicity testing, dangerous goods shipping, data backup, data breach notification, data dependent acquisition, data independent acquisition, data management, data portability, Data protection, Data sharing, data subject rights, data transparency, database synchronization, db/db mouse, de minimis threshold, decentralized procedure, declared value for customs, decommission pack, delegated regulation, desalting column, desensitization, desiccated storage, designer peptide, Dessau Veranstaltungszentrum, destruction process, development candidate, developmental toxicity, DEXA scan, DHL Express EU, DIA method, diabetes congress, diabetes cure research, dialysis cassette, dialysis tubing, diet induced obesity model, differential scanning calorimetry, digital wallet, DIO rat, direct delivery, direct inoculation, disability owned, disaster recovery, Discreet packaging, dispatch notification, dissociation constant, dissociation rate, distance selling threshold, disulfide bond formation, disulfide bridge analysis, disulfide mapping, diversity equity inclusion, DKMA Denmark, DMSO peptide solubility, Dortmund Westfalenhallen, dose ranging study, dose response curve, downregulation, DPD classic, drop shipment, drop test, drug development pipeline, drug discovery news, drug-drug interaction, dry ice shipment, DSEAR assessment, Düsseldorf Trade Fair, duty rate, E. coli expression, EASD annual meeting, EC50 calculation, eco friendly packaging, economy delivery, Edman degradation, educational use only, efficacy assessment, efflux pump, electronic lab notebook, electrophysiology, elemental impurity, ELISA kit, EMA authorization, EMA guideline, email campaign, Emax model, EMBL course, EMBO workshop, emergency response, employer liability, EMVS system, ENDO meeting, endocytosis, endotoxin tested, energy expenditure research, enhanced solubility, entry summary declaration, environmental safety, enzyme induction, EORI number, EP reference standard, EPS, equal opportunity employer, erasure request, ERC grant, Essen Messe, Ethereum, Ethical research, ethical sourcing, Ethics Committee approval, EU compliant lab supply, EU FMD directive, EU GMP Annex 1, EU peptide warehouse, EU representative, EU settlement scheme, EU-US Data Privacy Framework, eupeptideshop.org, EUR1 movement certificate, European Peptide Symposium, European research community, European science funding, euthanasia method, evidence based research, exempt supply, exit summary declaration, experimental biology tool, experimental chemical, experimental use only, expired product, expiry date monitoring, export declaration, expressed protein ligation, extended release, external quality assessment, Extracellular acidification rate, extractable leachable, eye protection, eyewash station, FAIR principles, fair trade, FAMHP Belgium, FAQ peptide, fast peptide delivery Europe, fast shipping Europe, fast track status, FDA approval process, FDA guidance, FEBS advanced course, FedEx priority, FEFO system, Fiera Milano, FIFO system, filter needle use, FIMEA Finland, Fira Barcelona, fire safety, first aid, fiscal representative, flammable storage, flash chromatography, flip top vial, flow chemistry, fluxomics, Fmoc chemistry, force majeure, forced degradation, forensic use exclusion, formulation patent, foundation research grant, fraction collection, Frankfurt Oder Messe, fraud prevention, Free shipping threshold, freeze dryer validation, freeze drying, freeze thaw stability, freeze thaw stability peptides, freezer alarm, freight forwarder, Fribourg Centre, fuel surcharge, fulfillment house, fume cupboard maintenance, functional bioassay, GB-NI trade, GDPR compliance, gel packs, gene expression analysis, generator backup, generic alternative, generic drug application, genetic obesity model, genotoxic impurity, Genotoxicity, GIP agonist research, Giropay, GLP compliance, GLP compliant research, GLP-1 agonist EU, GLP-1 GIP Glucagon triple agonist, GLP-1 research peptides EU, GLS parcel, glucagon ELISA, glucagon receptor agonist, glucagon secretion assay, glucose uptake assay, glutathione adduct, glycosylation analysis, GMP grade peptides, Google pay, Google Scholar profile, Gordon research conference, government research procurement, GPI anchor, GPRD general purpose reagent, Grade A, Grade B, Grade C, Grade D, Great Britain ordering, green chemistry, growth promotion test, guaranteed purity, gut peptide research, h-index, H&E staining, half-life determination, Halle Messe, Hamburg Messe, handling peptides safely, handling video, Hannover Messe, HAS assessment, hazard classification, health and safety policy, health technology assessment, heavy metals, help center, Helsinki Expo, hepatotoxicity, hERG assay, high fat diet study, high impact factor, high purity Germany, high purity peptides EU, high purity research chemicals, high purity Retatrutide, HMBC, holiday schedule, Horizon Europe project, hospital procurement, how to store Retatrutide, HPRA Ireland, HS code 29379000, HSQC, human consumption prohibited, humane endpoints, humidity stability, hydrophilic interaction HPLC, hypersensitivity, IACUC approval, IATA compliance, IC50 determination, ice pack shipping, Icelandic Medicines Agency, ICH guideline, ICH Q3C, ICH Q3D, ICS2 declaration, iDEAL, identification test, immunogenicity, immunohistochemistry, immunotoxicity, impact assessment, import duty peptides EU, import license, import one stop shop, import VAT deduction, improved efficacy, impurity profiling, in house method, in house standard, in vitro diagnostic device, incretin research, IND enabling studies, indirect calorimetry, industry partnership, industry standard peptides, INFARMED Portugal, influencer marketing, Informa exhibitions, Informed consent, infusion reaction, injection site reaction, innovative chemical tools, innovative research peptides, innovator product, input VAT recovery, INS-1 cells, Instagram science, institute research order, insulin ELISA, insulin secretion assay, insurance coverage, insurance value, intact mass analysis, intellectual property, inter laboratory comparison, intermediate precision, internal standard, internalization, international data transfer, intra EU acquisition, intra EU delivery, intra EU supply, inventory management, Investigational Medicinal Product Dossier (IMPD), investigational new drug, investigational use only, invoice discount, invoice payment, ion channel activity, ion channel panel, ion exchange HPLC, IOSS scheme, IQWiG evaluation, islet isolation, ISO 5, ISO 7, ISO 8, ISO 9001, ISO certified peptides, isoform, isothermal titration calorimetry, iTRAQ, IVD regulation, JP monograph, Karl Fischer, ketogenesis study, ketone body assay, Keystone symposium, Ki value, kidney disease research, Kiel Ostseehalle, kilo lab, kinase panel, Klarna, Koelnmesse, lab coat safety, lab consumables Europe, lab equipment exhibition, lab stock solutions, lab vlogger, label free quantitation, labor standards, laboratory developed test, laboratory peptides Netherlands, laboratory reagent, laboratory safety peptides, laboratory training, LAL test, laminar flow hood best practices, large scale peptide synthesis, LC-MS/MS bioanalysis, LDT validation, lead generation, lead optimization, lead supervisory authority, legitimate interest, Leipzig Messe, LGBTQ+ owned, licensing agreement, life science tools, lifecycle management, light sensitive storage, Lille Grand Palais, limit of detection, limit of quantification, limit test, line extension, linearity, LinkedIn scientist, Lipidomics, lipolysis assay, liver spheroid culture, long acting profile, loss on drying, lost package insurance, lot tracking peptides, low value shipment, Loyalty discount, loyalty points, Lübeck Musik- und Kongresshalle, LY3437943 buy, Lyon Eurexpo, lyophilization cycle, lyophilized stability, lysosomal degradation, MAA submission, Magdeburg Messe, mammalian expression, margin of safety, Marie Curie fellowship, market access, market authorization, marketing authorization application, marketing preference, marketplace facilitator, Marseille Chanot, Mass Spec verification, matrix effect, matrix matched standard, mature peptide, Maximum tolerated dose, medical device directive, medicinal chemistry, medRxiv, membrane filtration, Messe Basel, Messe Berlin, Messe Frankfurt, Messezentrum Wien, Meta analysis, metabolic cage study, metabolic disease modeling, metabolic drug development, metabolic flux analysis, metabolic health news, metabolic labeling, Metabolic research peptide, Metabolic syndrome research, metabolic triagonist, metabolism prediction, metabolite identification, Metabolomics, method development, method of use, method transfer, method validation, methylation, MHRA UK (post-Brexit), microbiological control, Micronucleus assay, microwave assisted synthesis, MIN6 cells, minimum effective dose, minority owned business, mitochondrial function, moisture content, molecular pharmacology, money back guarantee, MPA Sweden, MPLC system, MRI analysis, MRP, MSDS peptide, Munich Trade Fair, Mutagenicity, mutual recognition procedure, myristoylation, Nantes Cité, national competent authority, national post, national procedure, national repository, native chemical ligation, NEFA assay, nephrotoxicity, network pharmacology, neutralizing antibody, new peptide announcements, Newsletter signup, next day delivery, next generation molecule, next generation peptide, NFC chip, NICE guidance, NIPH Poland, nitrile gloves, nitrogen blanketing peptide, nitrosamine risk, NMR spectroscopy, no observed adverse effect level, NOESY, NOMA Norway, non compendial method, non hazardous chemical, normalization method, Northern Europe delivery, Northern Ireland delivery, Northern Ireland protocol, not for diagnostic use, not for drug use, novel formulation, novel obesity therapy research, novel therapeutics, Nuremberg Exhibition, ob/ob mouse, obesity research update, obesity week, OECD guideline, off target effects, OGYP. Budapest, Oil Red O staining, onboarding process, once weekly injection, one stop shop, online verification, open access research, open data, Oral bioavailability, ORCID iD, order confirmation email, order Retatrutide, organoid model, originator product, orphan drug designation, OSS regime, osteoarthitis research, out of hours response, Oxygen consumption rate, P-glycoprotein, pack verification, package integrity, pair feeding study, Palexpo Geneva, palmitoylation, parallel trade, Paris expo, passive packaging, Patch clamp, patent protection, patient recruitment, patient safety, patient support program, payment success rate, PayPal accepted, PayPal Credit, paysafecard, peak season surcharge, peptide content determination, peptide cyclization, peptide drug candidate, peptide drug design, peptide educational content, peptide expert advice, peptide fingerprinting, peptide for in vitro research, peptide for in vivo research, peptide legality, peptide manufacturer Europe, peptide mapping, peptide mapping MS/MS, Peptide purification, peptide reconstitution guide, peptide science conference, peptide shop EU, peptide solvent compatibility, peptide supplier Spain, peptide synthesis Europe, peptide synthesis technology, peptide therapeutics, peptide vendor Europe, peptides for research France, performance evaluation, periodic safety update report, Ph. Eur. monograph, pharma R&D department, pharmaceutical innovation, pharmaceutical research peptides, pharmacode, Pharmacodynamics, Pharmacokinetics, pharmacopoeia compliance, pharmacovigilance, pharmacy check, Phase 1 study, Phase 2 results, Phase 3 trial design, phase change material, PhD research peptides, phosphorylation cascade, phosphorylation site, photostability, pilot scale, polypharmacology, pooling strategy, post translational modification, post-marketing surveillance, postponed VAT accounting, Potsdam Metropolis Hall, PPE for research, precision, preclinical package, preclinical research compound, preclinical research tool, preferential origin, prefilter, premium research peptides, prenylation, Preparative HPLC, preprint server, pricing negotiation, primary drying, primary hepatocyte isolation, primary reference standard, primary standard, priority review, privacy notice, Privacy policy, private research facility, PRM assay, process development, process optimization, processing record, product liability, professional indemnity, proficiency testing, proficiency testing scheme, proforma invoice, promo code, propeptide, proteasomal degradation, protein precipitation extraction, Proteomics, Przelewy24, PTM analysis, public liability, public-private partnership, publication in peer review journal, Publons profile, PubMed citation, purification gradient, purity check, QALY calculation, QC release, QconCAT, qPCR primer, QR code, QT prolongation, quality assurance peptides, quality control peptides, quality control sample, radiolabeled peptide, RAI Amsterdam, range, REACH compliance, reactive metabolite, reagent qualification, real time stability, real-world evidence, receipt provided, receptor binding kinetics, receptor occupancy, receptor panel, recombinant peptide expression, reconstitution syringe, reconstitution time, reconstitution video, recovery, rectification request, recyclable materials, recycling pathway, reduce plastic waste, reduced side effects, reference listed drug, reference material, reference material storage, referral program, refrigerated storage, regulatory exclusivity, regulatory submission support, reimbursement decision, relabeling, reliable peptide shipping, remote area surcharge, renewal application, repackaging, repeat customer offer, repeat use procedure, repeatability, Replication study, reproducibility, Reproducibility crisis, Reproductive toxicity, research and development chemicals, research application only, research blog, research blogger, research chemical analogue, research chemical legislation EU, research chemicals EU compliant, Research collaboration, research data management, research exemption clause, research exemption VAT, Research news, research only disclaimer, research peptides Germany, research use only label, research use only peptides, research-grade material, ResearchGate profile, reshipment policy, residual moisture, residual solvent, residue on ignition, retail pharmacy, Retatrutide, Retatrutide 20mg kaufen Deutschland, Retatrutide 20mg vial price, Retatrutide animal study, Retatrutide Austria, Retatrutide Belgium, retatrutide CAS 2381089-83-2, retatrutide clinical trial research, retatrutide COA, Retatrutide Denmark, Retatrutide diabetes research, Retatrutide efficacy data, Retatrutide España compra, retatrutide europe, Retatrutide fatty liver research, retatrutide for sale, Retatrutide formula, Retatrutide forum discussion, Retatrutide France achat, Retatrutide Germany kaufen, retatrutide HPLC, Retatrutide in stock EU, Retatrutide Ireland, Retatrutide Italia, Retatrutide lab supply, Retatrutide lyophilized powder, Retatrutide MASLD research, Retatrutide mass spec, Retatrutide mechanism of action, retatrutide molecular weight, Retatrutide MS, retatrutide Netherlands, Retatrutide obesity research, Retatrutide peptide buy, Retatrutide Poland, Retatrutide prix France, Retatrutide protocol, Retatrutide receptor binding, Retatrutide reconstitution, Retatrutide research peptide, Retatrutide review, Retatrutide solubility, Retatrutide Sweden, Retatrutide technical data, Retatrutide vial 20mg, Return policy, returns handling, reverse charge mechanism, reversed phase HPLC, rFC assay, RFID tag, ring trial, risk assessment, risk assessment method statement, risk management plan, RLD, robustness, ROESY, Rostock Stadthalle, route scouting, ruggedness, RUO antibody, RUO chemicals, safety and security, safety database, safety features, Safety pharmacology, safety screen, safety shower, sample preservation, SAR study, Saturday delivery, scale up, scale up synthesis, Schrems II judgment, Schwerin Sport- und Kongresshalle, scientific breakthroughs, scientific evidence, scientific influencer, scientific lab supplies, scientific support team, Scopus author ID, Seahorse assay, seal integrity, Second messenger, secondary drying, secondary standard, secondary standard preparation, secondary structure analysis, Secure checkout, secure payment peptides, selectivity, selectivity profiling, self healing stopper, serialization, shelf life determination, shelf temperature, Shop pay, signal peptide, signal transduction, signature on delivery, signed courier, SIL peptide, SILAC, site inspection, size exclusion chromatography, sleep apnea research, small business enterprise, Sofort, solid phase extraction, solid-phase peptide synthesis, solvent standard, solvent store, Southern Europe delivery, spare receptor, specificity, spike in standard, spill kit, splice variant, SPPS, SRM/MRM assay, SSL encryption, stability indicating method, stability testing, stable isotope label, stablecoin, standard addition, standard contractual clauses, Standard operating procedure, Sterile filtration, sterile filtration peptides, sterile peptide vial, sterile technique peptide, sterility test, stock control, Stockholmsmässan, Strasbourg Zenith, structure-activity relationship, Stuttgart Messe, subcutaneous delivery, SUKL Czech Republic, sulfated ash, SUMOylation, supervisory authority, supplier diversity program, supplier questionnaire, surface plasmon resonance, sustainability, SWATH-MS, Swiss-US Data Privacy Framework, Swissmedic, syringe filter, system suitability, system suitability testing, Systematic review, systems biology, tamper evident, tamper evident packaging, targeted proteomics, tariff code, tax point, technology transfer, temperature controlled shipping, temperature controlled van, temperature data logger, Temperature excursion, temperature monitoring system, tender process, terminal sterilization, Terms of service, TFA content, therapeutic index, therapeutic window, thermal mapping, thermal shift assay, third party tested peptides, third-party logistics, time definite delivery, TIR carnet, tissue collection, tissue distribution, tissue histology, TMT labeling, TNT express, top peptide site, Toulouse MEETT, toxicogenomics, toxicology study, track and trace, tracked mail, tracking number provided, trade show exhibit, transgenic mouse model, transit procedure, Translational research, transport vibration, transporter activity, triangulation simplification, Triglyceride assay, triple hormone agonist, triple receptor agonist, tritium labeled, TRIUMPH trial research, trusted payment gateway, trusted peptide supplier, trusted source EU, Twitter academic, ubiquitination, UK Extension, UK representative, unique identifier, university lab supply, university purchase order, unsubscribe link, upload data, UPS power, UPS standard, US Privacy Shield, USDC, USP 87, USP 88, USP monograph, USP reference standard, UV spectrophotometry peptide, vacuum filtration, vacuum level, vacuum sealed peptide, validated method, validation data, validation study, variation application, VAT deferment, VAT e-commerce package, VAT invoice, VAT on research chemicals, VAT rate, vendor qualification, verification testing, veteran owned, veterinary use exclusion, volume discount, volume of distribution, waste management, Water content, water for injection peptides, Web of Science researcher ID, WeChat Pay, Western blot antibody, western diet intervention, Western Europe delivery, WHO international standard, wholesale research peptides, wholesaler distribution, women in STEM, workers compensation, working standard, working standard dilution, yeast expression, zero rated supply, ZIN review, Zucker rat

Description

Description

Premium Retatrutide (LY3437943) for Sale | 20mg per Vial | ≥99% Purity | 48-Hour Delivery Across EU & UK

Retatrutide (LY3437943): The Revolutionary Triple Agonist Redefining Metabolic Research

https://eupeptidelap.co.uk/ is proud to present Retatrutide 20mg (R&D Only) , a premium research-grade triple receptor agonist peptide manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with Retatrutide for sale that delivers exceptional purity, consistency, and documented quality .

Retatrutide (LY3437943) represents a groundbreaking advancement in metabolic research as the first-in-class triple agonist peptide targeting three key hormone receptors simultaneously: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon (GCG) receptor . This sophisticated 39-amino acid synthetic peptide is engineered to harness the complementary actions of all three incretin hormones, producing unprecedented metabolic effects that surpass even the most advanced dual agonists currently available .

The molecular formula of Retatrutide is C₂₂₁H₃₄₂N₄₆O₆₈, with a molecular weight of 4731.33 Da . Its unique structural design includes three non-coding amino acid residues at positions 2, 20, and 13—Aib2 (α-aminoisobutyric acid) provides resistance to DPP-4 degradation, Aib20 contributes to optimal GIP activity, and αMeL13 enhances GCG and GIP activity . The peptide backbone is conjugated to a C20 fatty diacid moiety via a linker at the lysine residue at position 17, enabling albumin binding as a pharmacokinetic half-life extension strategy .

The triple agonism approach leverages:

GLP-1 Receptor Activation: Enhances insulin secretion in response to glucose, slows gastric emptying, and acts directly on brain appetite centers to suppress hunger
GIP Receptor Activation: Stimulates insulin release, influences fat metabolism and storage, and may affect brain reward pathways associated with food
Glucagon Receptor Activation: Increases energy expenditure, promotes lipolysis (fat breakdown), and reduces fat accumulation in the liver—while the potent glucose-lowering effects of GLP-1 and GIP offset glucagon’s potential blood sugar-raising effects

For researchers seeking to buy peptide online EU for investigations into obesity pharmacotherapy, type 2 diabetes, metabolic syndrome, or non-alcoholic fatty liver disease (NAFLD), eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data . Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.

The Scientific Foundation of Retatrutide

Understanding the Triple Agonist Mechanism

To appreciate the innovation of Retatrutide, it’s essential to understand the hormones it mimics. The human body uses a complex network of signals to regulate appetite, blood sugar, and energy balance. Retatrutide simultaneously activates three key receptors in this network, creating a powerful, synergistic effect that addresses metabolic dysfunction from multiple angles .

Glucagon-Like Peptide-1 (GLP-1): Secreted by intestinal L-cells in response to meals, GLP-1 is a cornerstone of modern metabolic drugs. It enhances insulin secretion in a glucose-dependent manner (significantly reducing hypoglycemia risk), slows gastric emptying to increase feelings of fullness, and acts directly on the hypothalamus to suppress appetite . GLP-1 receptors are found in the pancreas, gastric mucosa, kidney, lung, heart, and brain regions including the hypothalamus, amygdala, and nucleus accumbens.

Glucose-Dependent Insulinotropic Polypeptide (GIP): Released from intestinal K cells postprandially, GIP was once thought less critical but has been re-evaluated following the success of dual agonists. GIP stimulates insulin secretion, reduces appetite by impacting gastric emptying, and influences adipose tissue by stimulating adipogenesis and inhibiting lipolysis . GIP receptors are expressed in pancreatic β-cells, adipose tissue, and the nervous system.

Glucagon: Produced in pancreatic α-cells, glucagon is traditionally known for raising blood sugar by stimulating hepatic glucose release. However, it also increases energy expenditure, promotes fat breakdown (lipolysis), and reduces hepatic fat accumulation . The challenge has always been harnessing these benefits without causing hyperglycemia—a challenge Retatrutide overcomes through balanced triple agonism.

In Vitro Activity and Receptor Selectivity

Retatrutide has been carefully engineered to achieve balanced activation of all three receptor types. In vitro studies using HEK-293 cell lines expressing human receptors demonstrate:

GIP Receptor Activity: Retatrutide exhibits potent GIP receptor agonism with an EC50 of 0.0643 nM, demonstrating approximately 8.9-fold greater potency than native human GIP(1-42)-NH₂
GLP-1 Receptor Activity: The peptide activates human GLP-1 receptors with an EC50 of 0.775 nM, approximately 2.5-fold less potent than native GLP-1(7-36)-NH₂
Glucagon Receptor Activity: Retatrutide activates human GCG receptors with an EC50 of 5.79 nM, approximately 2.9-fold less potent than native human glucagon

This balanced activation profile ensures that all three pathways contribute meaningfully to the compound’s metabolic effects, with the high GIP potency potentially driving enhanced adipocyte engagement and lipid metabolism .

Key Research Applications

Obesity and Weight Loss Research

Retatrutide is extensively used in studies investigating body weight regulation, adipose tissue biology, and energy homeostasis. Clinical trials have demonstrated unprecedented weight loss results that set a new high bar for obesity pharmacotherapy research .

Phase 2 Clinical Trial Results: The landmark Phase 2 randomized, double-blind, placebo-controlled trial published in the New England Journal of Medicine (2023) enrolled 338 adults with BMI ≥30 (or ≥27 with a weight-related comorbidity) without type 2 diabetes. Results after 48 weeks showed :

Unprecedented Weight Loss: Participants receiving 12 mg weekly achieved a mean weight reduction of 24.2% of initial body weight—translating to approximately 26.4 kg (58 pounds)
Dose-Dependent Efficacy: Weight loss effects were clearly dose-dependent
Mechanism Differentiation: Unlike dual agonists that primarily reduce weight through caloric restriction, Retatrutide’s addition of glucagon agonism increases energy expenditure by approximately 8-12%, creating a dual-mechanism approach to weight reduction

Energy Expenditure Studies: In diet-induced obese mouse models, Retatrutide treatment resulted in significantly increased energy expenditure compared to pair-fed controls, confirming that glucagon receptor activation contributes to weight loss through both reduced caloric intake and increased energy utilization .

Type 2 Diabetes Research

Retatrutide has demonstrated exceptional efficacy in glycemic control research :

Phase 2 Diabetes Study: In 281 T2D subjects (± metformin) over 36 weeks, mean HbA1c reductions reached 2.16% with Retatrutide compared to 1.36% with dulaglutide
Superior Efficacy: The triple agonist approach produced greater improvements in glycemic control than selective GLP-1 receptor agonism alone
Mechanism: The glucose-lowering effects of GLP-1 and GIP receptor activation offset any potential hyperglycemic effects of glucagon agonism, creating a self-regulating system

Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) Research

A particularly exciting finding from Phase 2 trials was Retatrutide’s powerful effect on liver fat :

Baseline Liver Fat: Participants had average liver fat content of approximately 20%
Post-Treatment Reduction: After 48 weeks on 12 mg dose, liver fat decreased by an average of over 86%
Complete Resolution: Nearly 86% of participants achieved complete resolution of excess liver fat (below 5%)
Mechanism: Glucagon receptor agonism directly promotes hepatic fat oxidation and reduces de novo lipogenesis, making Retatrutide uniquely positioned for NAFLD/NASH research

Cardiometabolic Research

Beyond weight loss, participants saw significant improvements in key health markers :

Blood Pressure Reduction: Dose-dependent decreases in both systolic and diastolic blood pressure
Lipid Profile Improvement: Reduced triglycerides, increased beneficial HDL cholesterol
Glycemic Normalization: Every participant with prediabetes at baseline in the 8 mg and 12 mg groups reverted to normal glycemic status by study end

Metabolic Flexibility and Substrate Utilization

Preclinical studies demonstrate that Retatrutide influences substrate selection, shifting metabolism toward increased fat oxidation while preserving carbohydrate sensitivity . In diet-induced obese mouse models, Retatrutide treatment resulted in:

Reduced respiratory exchange ratio (RER), indicating increased fat oxidation
Decreased hepatic triglyceride accumulation
Improved overall metabolic flexibility

Ongoing Phase 3 TRIUMPH Program Research

Based on highly successful Phase 2 results, Eli Lilly has launched an extensive Phase 3 clinical trial program (TRIUMPH) evaluating Retatrutide in diverse populations and for different indications :

Trial	Population	Primary Focus
TRIUMPH-1	Chronic weight management	Obesity with/without T2D
TRIUMPH-2	Obstructive sleep apnea	OSA in obesity
TRIUMPH-3	Obese subjects with CVD	Cardiovascular outcomes
TRIUMPH-4	Knee osteoarthritis	Pain and function
TRIUMPH-5	Chronic low back pain	Pain management
TRIUMPH-CV	Cardiovascular/renal outcomes	Major adverse cardiac events
TRANSCEND-T2D	Type 2 diabetes	Glycemic control and weight

Quality Assurance: Setting the Standard for Research Compounds

Manufacturing Excellence

eupeptidelap.co.uk sources Retatrutide from certified GMP facilities with rigorous quality control protocols :

HPLC Purity Analysis: ≥99% purity verified by high-performance liquid chromatography
Mass Spectrometry Verification: Molecular weight confirmation via LC-HRMS
Batch-Specific Certificates of Analysis: Complete documentation for each production run
Regulatory Compliance: Research Use Only (RUO) labeling with proper documentation
Safety Data Sheets (SDS): Provided with every order for safe handling

Chemical and Product Specifications

Specification	Detail
Product Name	Retatrutide (LY3437943) – R&D Only
CAS Number	2381089-83-2
Molecular Formula	C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight	4731.33 Da
Amino Acid Length	39 amino acids
Purity	≥99% (HPLC verified)
Appearance	White to off-white lyophilized solid
Solubility	H₂O: 20 mg/mL (ultrasonic; adjust pH to 9 with aqueous NH₃); DMSO: 50 mg/mL (ultrasonic)
Mechanism	Triple GLP-1/GIP/Glucagon receptor agonist
Storage (Powder)	-20°C to -80°C; stable up to 2 years at -80°C, 1 year at -20°C; protect from light and moisture
Storage (Reconstituted)	2-8°C for several weeks; aliquot to avoid freeze-thaw cycles
Shipping	Ambient temperature with protective packaging; cold chain available
Intended Use	Research and laboratory use only
Documentation	Certificate of Analysis, SDS provided

Stability and Handling Guidelines

Lyophilized Powder Storage: Retatrutide raw powder should be stored at -20°C to -80°C in a dry, dark environment, protected from light and moisture. In its lyophilized form, it can maintain potency for up to 2 years at -80°C and 1 year at -20°C. Use manual-defrost freezers or chest freezers rather than frost-free units to avoid temperature fluctuations. Store vials in the back of freezers (not door compartments) and maintain detailed temperature logs.

Reconstitution Protocol :

Allow vial and solvent to reach ambient temperature before opening to prevent condensation
Reconstitute using bacteriostatic water or sterile solvent according to research protocol
Inject solvent gently at a 45-degree angle, allowing it to run down the inside wall
Swirl gently—do not shake—to dissolve completely
Use fresh sterile needles for each vial access
Clean rubber stoppers with alcohol swabs before each puncture

Reconstituted Solution Storage : Once reconstituted, store at 2-8°C (refrigeration). Most formulations remain stable for several weeks. If freezing is necessary, aliquot into multiple smaller vials containing single-use amounts to minimize freeze-thaw cycles. Thaw completely in refrigerator over 24 hours—do not refreeze after use. When in solution and maintained sealed, away from moisture and light, it is stable for 6 months at -80°C and 1 month at -20°C.

Protection from Light and Moisture:

Use amber or opaque vials to block UV light
Transfer to light-blocking containers if original packaging is transparent
Keep vials tightly sealed with desiccants when possible
Allow frozen vials to reach room temperature in a desiccator before opening

Key Benefits

Premium Quality Manufacturing: GMP-certified production, ≥99% HPLC-verified purity
First-In-Class Triple Agonist: Simultaneous GLP-1, GIP, and glucagon receptor activation for synergistic research applications
High Concentration: 20mg per vial—ideal quantity for targeted metabolic studies
Unprecedented Weight Loss Research: Enables investigation of 24.2% body weight reduction in obesity models
Dual-Mechanism Weight Loss: Combines reduced caloric intake (GLP-1/GIP) with increased energy expenditure (glucagon)
NAFLD/NASH Research: Reduces liver fat by >86% with nearly complete resolution in Phase 2
Glycemic Control Studies: HbA1c reductions up to 2.16% in T2D research models
Energy Expenditure Research: Glucagon agonism increases basal metabolic rate by 8-12% in preclinical models
Cardiometabolic Research: Improves blood pressure, lipid profiles, and insulin sensitivity
Appetite Regulation Studies: Triple mechanism targeting hypothalamic and reward pathways
Lipid Metabolism Research: Reduces triglycerides and increases HDL cholesterol
Metabolic Flexibility Studies: Shifts substrate utilization toward increased fat oxidation
Prediabetes Studies: 100% normalization of prediabetes at higher doses
Superior Efficacy: Outperforms dual agonists in head-to-head comparisons
Extended Half-Life: C20 diacid confers albumin binding and prolonged duration
DPP-4 Resistant: Aib2 modification provides enzymatic stability
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
Proper RUO Labeling: Full compliance with research-use-only regulations
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
EU Sourced: Available from within the European Union

Frequently Asked Questions

Q: Is Retatrutide 20mg (R&D Only) suitable for human consumption?

A: No. Retatrutide 20mg (R&D Only) from eupeptidelap.co.uk is strictly for research and laboratory use only . It is not for human or animal consumption, and must not be used for therapeutic, diagnostic, or clinical applications. While Retatrutide is being investigated in clinical trials by Eli Lilly and is expected to reach the market as early as 2026, research-grade material is intended for investigational purposes only . Regulatory agencies have issued warnings against unapproved versions sold without proper RUO status . Researchers must handle this compound in accordance with institutional safety guidelines and local regulations.

Q: Is it legal to sell Retatrutide for research purposes in the UK?

A: The sale of unlicensed peptides like Retatrutide under “research use only” labeling occupies a legal grey area but is permissible under strict conditions . Legitimate buyers include academic labs, CROs, pharmaceutical R&D, and licensed clinics conducting non-human research . Proper documentation including Certificates of Analysis, Safety Data Sheets, and explicit RUO labeling is mandatory . The Medicines and Healthcare products Regulatory Agency (MHRA) may take enforcement action if marketing materials or user reviews indicate personal human use . Compliance with REACH and labeling standards is essential for UK/EU sales .

Q: What purity level can I expect when I buy Retatrutide from eupeptidelap.co.uk?

A: All Retatrutide from eupeptidelap.co.uk is tested to ≥99% purity by HPLC . Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.

Q: How effective is Retatrutide for weight loss in research models?

A: In clinical trials, Retatrutide has demonstrated unprecedented weight loss results. Phase 2 studies at 48 weeks showed 24.2% average weight loss at 12 mg dose—the highest weight loss recorded for any anti-obesity medication to date . This degree of weight loss is similar to that achieved with some bariatric surgery procedures . The mechanism differs from dual agonists by adding increased energy expenditure (8-12%) to reduced caloric intake .

Q: How should I store Retatrutide for long-term stability?

A: Store lyophilized Retatrutide powder at -20°C to -80°C, protected from light and moisture . Powder is stable for up to 2 years at -80°C and 1 year at -20°C . Use manual-defrost freezers and store vials in the back (not doors). After reconstitution, store at 2-8°C for several weeks or aliquot into single-use portions and freeze at -80°C for up to 6 months or -20°C for up to 1 month . Avoid repeated freeze-thaw cycles.

Q: What is the molecular weight and formula of Retatrutide?

A: Retatrutide has the molecular formula C₂₂₁H₃₄₂N₄₆O₆₈ and a molecular weight of 4731.33 Da . It is a 39-amino acid peptide containing three non-coding amino acid residues at positions 2, 13, and 20, engineered for balanced activation of GLP-1, GIP, and glucagon receptors .

Q: What is the mechanism of action of Retatrutide?

A: Retatrutide is a first-in-class triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously . GLP-1 and GIP enhance insulin secretion, suppress appetite, and slow gastric emptying, while glucagon increases energy expenditure and promotes fat breakdown . The glucose-lowering effects of GLP-1 and GIP offset glucagon’s potential blood sugar-raising effects, creating a self-regulating synergistic system .

Q: What research areas commonly use Retatrutide?

A: Retatrutide is widely used in obesity and weight loss research, type 2 diabetes research, NAFLD/NASH research, cardiometabolic studies, appetite regulation research, energy expenditure studies, and metabolic flexibility research .

Q: Do you ship Retatrutide to EU countries?

A: Yes. As a dedicated EU peptide supplier, we ship Retatrutide to all European Union member states with our guaranteed 48 hour delivery peptide service. Shipments must comply with EU REACH and labeling standards for RUO compounds . Our EU fulfilment centre ensures rapid delivery without customs delays.

Q: What documentation do you provide with Retatrutide orders?

A: Every order includes a Certificate of Analysis with batch-specific purity data and a Safety Data Sheet (SDS) for safe handling . Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.

Q: How does Retatrutide compare to Tirzepatide?

A: Retatrutide (triple GLP-1/GIP/glucagon agonist) represents an advancement beyond Tirzepatide (dual GIP/GLP-1 agonist) . Phase 2 trials showed 24.2% weight loss with Retatrutide at 48 weeks compared to approximately 22% with Tirzepatide at 72 weeks . The addition of glucagon agonism drives enhanced effects on energy expenditure (8-12% increase) and liver fat reduction (>86%), mechanisms not addressed by dual agonists . Preclinical studies confirm Retatrutide leads to greater weight loss than tirzepatide in diet-induced obese mouse models .

Q: Does Retatrutide affect liver fat?

A: Yes, dramatically. In Phase 2 studies, participants on 12 mg dose saw liver fat decrease by over 86% from baseline (approximately 20% down to <5%). Nearly 86% achieved complete resolution of excess liver fat . This effect is attributed to glucagon receptor agonism, which directly promotes hepatic fat oxidation and reduces de novo lipogenesis.

Q: What are the common adverse effects observed in Retatrutide trials?

A: The most common adverse events are gastrointestinal: nausea, diarrhea, constipation, and decreased appetite . These effects are consistent with the incretin mimetic drug class and are dose-related. The safety profile is similar to other incretin mimetics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Q: Do you offer bulk quantities of Retatrutide for institutional research?

A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs.

Advance Your Research with Retatrutide 20mg (R&D Only)

eupeptidelap.co.uk is your trusted source for Retatrutide 20mg (R&D Only) , the premium choice for researchers investigating metabolic disorders, obesity pharmacotherapy, diabetes, and NAFLD/NASH. As the first-in-class triple GLP-1/GIP/glucagon receptor agonist, Retatrutide represents a revolutionary tool for exploring the synergistic actions of all three incretin pathways and their unprecedented therapeutic potential. ...........................................

Whether you are exploring weight loss mechanisms, designing diabetes studies, investigating hepatic steatosis, or researching cardiometabolic outcomes, our rigorously tested compound provides the quality and consistency your work demands.

Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.

........ .. .. google